Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVRBusiness Wire • 03/11/24
Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/07/24
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare ConferenceBusiness Wire • 02/23/24
Edwards' EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid ValveBusiness Wire • 02/02/24
Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 02/01/24
Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength?Zacks Investment Research • 02/01/24
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/02/24